0: At present, chemotherapy with the combination of pyrimethamine and sulfadiazine followed by azithromycin, clindamycin, atovaquone, etc., is considered as the preferred treatment for toxoplasmosis; however, studies in recent years have demonstrated that these drugs are associated with some side effects such as osteoporosis, and teratogenic effects mostly in immune-compromised patients [ 5, 6].
1: Atovaquone, a hydroxynaphthoquinone derivative, has potent activity against tissue cysts through the blocking respiratory chain of the  Toxoplasma; therefore, it is broadly used for in vivo activity against  T. gondii during both infection stages [ 7].
